Results 191 to 200 of about 74,143 (357)
Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor–Related Esophagitis [PDF]
, 2021 Kavea Panneerselvam +11 more
openalex +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Introduction Gastrointestinal cancers account for 26% of cancer incidence and 35% of cancer‐related deaths globally. Early detection is crucial but often limited by white light endoscopy (WLE), which misses subtle lesions. Texture and color enhancement imaging (TXI), introduced in 2020, enhances texture, brightness, and color, addressing WLE's
Muhammad Shahzil +10 more
wiley +1 more source
Plant Biotechnology Persa, 2019 Introduction: Gastroesophageal reflux disease is a common disorder of the digestive tract. Esophageal mucosa exposure to gastric acid can lead to mucosal damage such as esophagitis.
Mosayed Moradniani, Saber Abbaszadeh
doaj
Incentives for Clinical Trials [PDF]
Who gains from more information on the quality of pharmaceutical drugs? Are there incentives for voluntary post-approval clinical trials among pharmaceutical companies?
Grönqvist, Erik, Lundin, Douglas
core
The Esophageal Microbiome in Eosinophilic Esophagitis [PDF]
Gastroenterology, 2016 openaire +2 more sources
DEN Open, Volume 6, Issue 1, April 2026.Abstract Gastric abscess is a rare condition caused by gastric barrier damage. It is easily misdiagnosed in clinical practice as a cancer recurrence or submucosal tumor, especially after surgery or endoscopic submucosal dissection. With a relatively high mortality rate, the cause and clinical characteristics of gastric abscesses are obscure.
Jia Xie, Mo‐Jin Wang, Rui Wang
wiley +1 more source
A 44‐year‐old man with esophageal ulcer
Clinical Case Reports, 2022 Delvise T. Fogwe +2 more
doaj +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Background and aims Endoscopic anti‐reflux therapies like anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation have shown efficacy for gastroesophageal reflux disease (GERD) in systematic reviews and meta‐analyses. Anti‐reflux mucoplasty (ARM‐P), a refinement of ARMS, incorporates immediate closure of the resection site to reduce ...
Kazuki Yamamoto +11 more
wiley +1 more source
Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitors [PDF]
, 2023 Twan Sia +10 more
openalex +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Endoscopic antireflux therapy is a novel endoscopic treatment for refractory gastroesophageal reflux disease. We developed antireflux myoplasty (AR‐MP), a modified version of antireflux mucoplasty (ARM‐P), in which exposed bilateral sling fibers are sutured directly via endoscopic hand‐suturing.
Hironari Shiwaku +9 more
wiley +1 more source